VENKY'S (INDIA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,805 INR | +1.22% |
|
+2.57% | -7.52% |
| 03-19 | Venky's Begins Commercial Production of Veterinary Medicine Products in Maharashtra, India | MT |
| 03-19 | Venky's Limited Announces Commencing Commercial Production for AHP Unit At Kesurdi, Satara | CI |
| Sales 2022 | 44B 528M 722M | Sales 2023 | 42.34B 508M 694M | Capitalization | 20.33B 244M 333M |
|---|---|---|---|---|---|
| Net income 2022 | 1.65B 19.77M 27.02M | Net income 2023 | 705M 8.46M 11.56M | EV / Sales 2022 | 0.71 x |
| Net Debt 2022 | 1.23B 14.74M 20.15M | Net Debt 2023 | 799M 9.59M 13.11M | EV / Sales 2023 | 0.5 x |
| P/E ratio 2022 |
18.3
x | P/E ratio 2023 |
28.8
x | Employees | 5,664 |
| Yield 2022 |
0.61% | Yield 2023 |
0.42% | Free-Float | 33.5% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.22% | ||
| 1 week | +2.57% | ||
| Current month | +17.24% | ||
| 1 month | +16.09% | ||
| 3 months | -8.30% | ||
| 6 months | -7.71% | ||
| Current year | -7.52% |
1 week
1 745.00
1 835.00
1 month
1 544.001 888.00
Current year
1 531.002 087.00
1 year
1 531.002 314.90
3 years
1 421.103 955.00
5 years
580.103 955.00
10 years
183.734 725.00
| Managers | Title | Age | Since |
|---|---|---|---|
Balaji Rao Banda
CEO | Chief Executive Officer | 51 | 94-12-31 |
J. K. Handa
DFI | Director of Finance/CFO | 65 | 81-05-12 |
Danveer Singh
COO | Chief Operating Officer | 55 | 93-12-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 87-12-31 | |
| Director/Board Member | 59 | 94-12-31 | |
Balaji Rao Banda
CEO | Chief Executive Officer | 51 | 94-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1,805 | +1.22% | 31,799 |
| 24-04-25 | 1,783 | -0.36% | 13,524 |
| 24-04-24 | 1,789 | +1.85% | 31,905 |
| 24-04-23 | 1,757 | -0.87% | 19,549 |
| 24-04-22 | 1,772 | +0.73% | 27,462 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am
More quotes
Venky's (India) Limited is an India-based company, which is engaged in the production of specific pathogen free (SPF) eggs, chicken processing, broiler and layer breeding, animal health products, poultry feed, soya bean extract and many more in the poultry sector. The Company's segments include Poultry and Poultry Products, Animal Health Products, and Oilseed. The Poultry and Poultry Products segment produces and sells chicks, grownup commercial broiler, processed chicken, SPF eggs, poultry feed and other miscellaneous poultry products. The Animal Health Products segment produces and sells medicines and other health products for birds. The Oilseed segment produces and sells edible refined soya oil and soya de-oiled cake. The Company's animal healthcare products include nutritional supplements, toxin binders, early chick nutrition, liver tonics, acidifiers, growth promoters, iron tonic, antibiotics, anticoccidial, anti-mycoplasma, dewormers, anti-gout, electrolytes and certification.
Sector
Fishing & Farming
Calendar
2024-05-09
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +12.78% | 3.29B | |
| -95.58% | 1.61B | |
| -0.48% | 1.61B | |
| -2.37% | 1.25B | |
| -2.40% | 1.22B | |
| -.--% | 1.22B | |
| -11.54% | 1.21B | |
| -10.44% | 1.2B | |
| 0.00% | 1.19B |
- Stock Market
- Equities
- VENKEYS Stock
- VENKEYS Stock
